Gary A. Cameron

951 total citations
26 papers, 722 citations indexed

About

Gary A. Cameron is a scholar working on Pharmacology, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Gary A. Cameron has authored 26 papers receiving a total of 722 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pharmacology, 6 papers in Molecular Biology and 5 papers in Cellular and Molecular Neuroscience. Recurrent topics in Gary A. Cameron's work include Drug Transport and Resistance Mechanisms (4 papers), Cannabis and Cannabinoid Research (4 papers) and Pharmacogenetics and Drug Metabolism (4 papers). Gary A. Cameron is often cited by papers focused on Drug Transport and Resistance Mechanisms (4 papers), Cannabis and Cannabinoid Research (4 papers) and Pharmacogenetics and Drug Metabolism (4 papers). Gary A. Cameron collaborates with scholars based in United Kingdom, United States and Sweden. Gary A. Cameron's co-authors include Helen F. Galley, Nigel R. Webster, Damon A. Lowes, Lorna Aucott, Gabrielle Hawksworth, Lucy J. Elrick, Carylyn J. Marek, Matthew C. Wright, Tibor Harkany and Giuseppe Tortoriello and has published in prestigious journals such as Nature Communications, Journal of Neuroscience and PLoS ONE.

In The Last Decade

Gary A. Cameron

24 papers receiving 713 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gary A. Cameron United Kingdom 13 237 154 119 105 93 26 722
Kellie Larsen United States 12 429 1.8× 167 1.1× 107 0.9× 51 0.5× 88 0.9× 19 965
Xóchitl Trujillo Mexico 17 150 0.6× 196 1.3× 82 0.7× 20 0.2× 120 1.3× 120 1.0k
Chioma Izzi‐Engbeaya United Kingdom 16 61 0.3× 370 2.4× 83 0.7× 106 1.0× 93 1.0× 52 1.1k
Khalid M. Elased United States 24 119 0.5× 395 2.6× 150 1.3× 144 1.4× 201 2.2× 50 1.6k
Jin Fu China 11 557 2.4× 412 2.7× 112 0.9× 61 0.6× 116 1.2× 27 1.2k
Belisario E. Fernández Argentina 18 72 0.3× 352 2.3× 68 0.6× 91 0.9× 149 1.6× 96 1.1k
Fizza Naqvi Pakistan 14 68 0.3× 123 0.8× 112 0.9× 17 0.2× 100 1.1× 32 980
Amelia Rı́os Mexico 17 74 0.3× 228 1.5× 137 1.2× 106 1.0× 39 0.4× 42 887
Federico Mallo Spain 23 77 0.3× 245 1.6× 230 1.9× 352 3.4× 77 0.8× 50 1.3k
Elena Capoccia Italy 14 220 0.9× 258 1.7× 105 0.9× 14 0.1× 71 0.8× 18 714

Countries citing papers authored by Gary A. Cameron

Since Specialization
Citations

This map shows the geographic impact of Gary A. Cameron's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary A. Cameron with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary A. Cameron more than expected).

Fields of papers citing papers by Gary A. Cameron

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gary A. Cameron. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary A. Cameron. The network helps show where Gary A. Cameron may publish in the future.

Co-authorship network of co-authors of Gary A. Cameron

This figure shows the co-authorship network connecting the top 25 collaborators of Gary A. Cameron. A scholar is included among the top collaborators of Gary A. Cameron based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gary A. Cameron. Gary A. Cameron is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Larcombe, Daniel E., Iryna Bohovych, Arnab Pradhan, et al.. (2023). Glucose-enhanced oxidative stress resistance—A protective anticipatory response that enhances the fitness of Candida albicans during systemic infection. PLoS Pathogens. 19(7). e1011505–e1011505. 12 indexed citations
3.
Tortoriello, Giuseppe, Susana Romani, Gareth Williams, et al.. (2020). Genetic Manipulation of sn-1-Diacylglycerol Lipase and CB 1 Cannabinoid Receptor Gain-of-Function Uncover Neuronal 2-Linoleoyl Glycerol Signaling in Drosophila melanogaster. Cannabis and Cannabinoid Research. 6(2). 119–136. 9 indexed citations
4.
Fraga, Lucas Rosa, et al.. (2018). The Primodos components Norethisterone acetate and Ethinyl estradiol induce developmental abnormalities in zebrafish embryos. Scientific Reports. 8(1). 2917–2917. 9 indexed citations
5.
McLay, James S., Thomas Engelhardt, Baba Sulemana Mohammed, et al.. (2017). The pharmacokinetics of intravenous ketorolac in children aged 2 months to 16 years: A population analysis. Pediatric Anesthesia. 28(2). 80–86. 8 indexed citations
6.
Li, Jun, Gary A. Cameron, & Heather Wallace. (2015). Decreased sensitivity to aspirin is associated with altered polyamine metabolism in human prostate cancer cells. Amino Acids. 48(4). 1003–1012. 12 indexed citations
7.
Tillmann, Anna, Zhikang Yin, Carmen Herrero‐de‐Dios, et al.. (2015). Integrative Model of Oxidative Stress Adaptation in the Fungal Pathogen Candida albicans. PLoS ONE. 10(9). e0137750–e0137750. 54 indexed citations
8.
Tillmann, Anna, Karin Strijbis, Gary A. Cameron, et al.. (2015). Contribution of Fdh3 and Glr1 to Glutathione Redox State, Stress Adaptation and Virulence in Candida albicans. PLoS ONE. 10(6). e0126940–e0126940. 36 indexed citations
9.
Engelhardt, Thomas, et al.. (2015). The enantioselective population pharmacokinetics of intravenous ketorolac in children using a stereoselective assay suitable for microanalysis. Journal of Pharmacy and Pharmacology. 67(9). 1179–1187. 6 indexed citations
10.
Alpár, Alán, Giuseppe Tortoriello, Daniela Calvigioni, et al.. (2014). Endocannabinoids modulate cortical development by configuring Slit2/Robo1 signalling. Nature Communications. 5(1). 4421–4421. 56 indexed citations
11.
Galley, Helen F., et al.. (2014). Melatonin as a potential therapy for sepsis: a phase I dose escalation study and an ex vivo whole blood model under conditions of sepsis. Journal of Pineal Research. 56(4). 427–438. 129 indexed citations
12.
Mohammed, Baba Sulemana, Thomas Engelhardt, Gary A. Cameron, et al.. (2012). Population pharmacokinetics of single-dose intravenous paracetamol in children. British Journal of Anaesthesia. 108(5). 823–829. 22 indexed citations
13.
Ridge, S., et al.. (2011). Cannabinoids and bone: endocannabinoids modulate human osteoclast function in vitro. British Journal of Pharmacology. 165(8). 2584–2597. 61 indexed citations
14.
Riches, Zoe, Gary A. Cameron, & Gabrielle Hawksworth. (2011). Transporter mediated uptake and efflux of antiretroviral drugs: Potential for drug–drug interactions. Toxicology. 290(2-3). 127–128. 1 indexed citations
15.
Mohammed, Baba Sulemana, et al.. (2010). Can finger‐prick sampling replace venous sampling to determine the pharmacokinetic profile of oral paracetamol?. British Journal of Clinical Pharmacology. 70(1). 52–56. 49 indexed citations
16.
Keimpema, Erik, Klaudia Barabás, Yury M. Morozov, et al.. (2010). Differential Subcellular Recruitment of Monoacylglycerol Lipase Generates Spatial Specificity of 2-Arachidonoyl Glycerol Signaling during Axonal Pathfinding. Journal of Neuroscience. 30(42). 13992–14007. 91 indexed citations
17.
Sutherland, Alasdair, Gary A. Cameron, D. M. Alexander, & James D. Hutchison. (2008). Proinflammatory Markers in Prediction of Posttraumatic Psychological Symptoms: A Prospective Cohort Study. Mediators of Inflammation. 2008(1). 640659–640659. 2 indexed citations
18.
Cameron, Gary A., Carylyn J. Marek, Emma Louise Haughton, et al.. (2004). Mechanism of action of the antifibrogenic compound gliotoxin in rat liver cells. Hepatology. 40(1). 232–242. 56 indexed citations
19.
Cameron, Gary A., et al.. (2000). Regulation of deiodinase activity by cellular redox status. Toxicology. 148(1). 27–28. 1 indexed citations
20.
Scott, AK, et al.. (1991). Interaction of metoprolol with lorazepam and bromazepam. European Journal of Clinical Pharmacology. 40(4). 405–409. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kellie Larsen Breakdown of academic impact, for papers by Xóchitl Trujillo Breakdown of academic impact, for papers by Chioma Izzi‐Engbeaya Breakdown of academic impact, for papers by Khalid M. Elased Breakdown of academic impact, for papers by Jin Fu Breakdown of academic impact, for papers by Belisario E. Fernández Breakdown of academic impact, for papers by Fizza Naqvi Breakdown of academic impact, for papers by Amelia Rı́os Breakdown of academic impact, for papers by Federico Mallo Breakdown of academic impact, for papers by Elena Capoccia
Rankless by CCL
2026